What are the methods to increase VEGF expression and extremity vascular circulation in patients with peripheral arterial disease? 在外周动脉疾病(PAD)患者中,有什么方法可以增加VEGF表达和下肢血管循环?
ABI is significant in treatment of patients with peripheral arterial disease. ABI在下肢外周动脉病患者的治疗中可起重要的指导作用。
Conclusions & Thus, lower reactive hyperemia is associated with increased cardiovascular risk in patients with peripheral arterial disease. 研究发现,外周动脉疾病(PAD)的患者反应性充血降低与增加的心血管风险有关。
In patients with peripheral arterial disease, as in patients with coronary artery disease or cerebrovascular disease, major bleeding was independently associated with major ischemic complications. 外周血管疾病患者,与冠状动脉疾病或脑血管疾病患者一样,大出血与主要缺血并发症独立相关。
The same gene is also being targeted to treat peripheral arterial disease which causes blocked arteries in the limbs. VEGF-A基因同样是针对外周动脉疾病(PAD)的治疗的靶基因,外周动脉疾病(PAD)是一种能够导致四肢动脉阻滞的疾病。